Back to Compound Explorer

Valerenic acid

Clinical trial

Mechanism of Action

GABA-A receptor β3 subunit positive allosteric modulation — distinct from benzodiazepine binding site; reduces GABA reuptake
GABA-A receptor positive allosteric modulation at the beta-3 subunit; inhibition of GABA transaminase increasing synaptic GABA levels

Research Notes

Primary anxiolytic compound. GABA-A β3 selectivity demonstrated by Khom et al. Sedative effects enhanced by valepotriates. Clinical data largely extrapolated from V. officinalis.

ValerianWestern

Valerenic acid is the primary anxiolytic and sedative compound. Multiple RCTs demonstrate improved sleep quality with 300-600mg valerian extract. Meta-analysis supports modest but significant sleep benefits.

Found In 2 Herbs

3D Molecular Structure

Sesquiterpenoid carboxylic acid
Drag to rotate · Click atoms to explore

Valerenic acid

Sesquiterpenoid carboxylic acidModified terpenes with diverse biological activities

Representative pattern: C₁₀H₁₆O

Atoms
Carbon
Oxygen
Hydrogen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.